Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Tff Pharmaceuticals Inc (TFFP)

Tff Pharmaceuticals Inc (TFFP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,583
  • Shares Outstanding, K 2,519
  • Annual Sales, $ 730 K
  • Annual Income, $ -21,240 K
  • 60-Month Beta 1.29
  • Price/Sales 10.19
  • Price/Cash Flow N/A
  • Price/Book 0.64
Trade TFFP with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -2.20
  • Number of Estimates 1
  • High Estimate -2.20
  • Low Estimate -2.20
  • Prior Year -4.75
  • Growth Rate Est. (year over year) +53.68%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.51 +18.44%
on 04/22/24
7.45 -60.10%
on 03/26/24
-4.43 (-59.83%)
since 03/25/24
3-Month
2.51 +18.44%
on 04/22/24
11.00 -72.97%
on 03/20/24
-2.10 (-41.36%)
since 01/25/24
52-Week
2.51 +18.44%
on 04/22/24
21.25 -86.01%
on 05/05/23
-10.78 (-78.38%)
since 04/25/23

Most Recent Stories

More News
Novavax (NVAX) Reports Q1 Loss, Lags Revenue Estimates

Novavax (NVAX) delivered earnings and revenue surprises of -0.89% and 40.99%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

NVAX : 3.97 (-4.34%)
TFFP : 2.97 (-1.23%)
Atara Biotherapeutics (ATRA) Reports Q1 Loss, Lags Revenue Estimates

Atara Biotherapeutics (ATRA) delivered earnings and revenue surprises of -80% and 96.75%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

ATRA : 0.6834 (-4.38%)
TFFP : 2.97 (-1.23%)
Celldex Therapeutics (CLDX) Reports Q1 Loss, Tops Revenue Estimates

Celldex (CLDX) delivered earnings and revenue surprises of 1.59% and 157.87%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

CLDX : 36.78 (-0.65%)
TFFP : 2.97 (-1.23%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TFF Pharmaceuticals, Inc. - TFFP

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of TFF Pharmaceuticals, Inc. ("TFF" or the "Company") (NASDAQ: TFFP). Such...

TFFP : 2.97 (-1.23%)
TFF Pharmaceuticals, Inc. (TFFP) Q2 2022 Earnings Call Transcript

TFFP earnings call for the period ending June 30, 2022.

TFFP : 2.97 (-1.23%)
Wall Street Analysts Think TFF Pharmaceuticals, Inc. (TFFP) Could Surge 233%: Read This Before Placing a Bet

The mean of analysts' price targets for TFF Pharmaceuticals, Inc. (TFFP) points to a 233.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement...

TFFP : 2.97 (-1.23%)
TFF Pharmaceuticals to Participate at the H.C. Wainwright Global Investment Conference

FORT WORTH, Texas, May 20, 2022 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on...

TFFP : 2.97 (-1.23%)
TFF Pharmaceuticals, Inc. (TFFP) Q1 2022 Earnings Call Transcript

TFFP earnings call for the period ending March 31, 2022.

TFFP : 2.97 (-1.23%)
TFF Pharmaceuticals, Inc. (TFFP) Reports Q1 Loss, Misses Revenue Estimates

TFF Pharmaceuticals, Inc. (TFFP) delivered earnings and revenue surprises of 13.16% and 33%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

TFFP : 2.97 (-1.23%)
ARMP : 2.59 (+3.60%)
TFF Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update

Announced Collaboration with Catalent to Further Expand Thin Film Freezing Applications with a Focus on Biologic Drug Development Announced Second CRADA...

TFFP : 2.97 (-1.23%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

TFF Pharmaceuticals Inc. is an early-stage biopharmaceutical company. It is focused on the development and commercialization of inhalation products for the treatment of chronic respiratory diseases and lung conditions. TFF Pharmaceuticals Inc. is based in Austin, Texas.

See More

Key Turning Points

3rd Resistance Point 3.50
2nd Resistance Point 3.31
1st Resistance Point 3.16
Last Price 2.97
1st Support Level 2.83
2nd Support Level 2.64
3rd Support Level 2.49

See More

52-Week High 21.25
Fibonacci 61.8% 14.09
Fibonacci 50% 11.88
Fibonacci 38.2% 9.67
Last Price 2.97
52-Week Low 2.51

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar